📣 Congratulations to Moodmon, the project led by the Polish company Britenet, an InnoStars partner, for being awarded €1 million in funding through EIT Health’s prestigious Flagship Call. With the support of a distinguished European consortium, they are now set to obtain a CE mark, conduct clinical trials, and showcase its real-world healthcare benefits. Additionally, the team is working on creating a legal framework for AI retraining without the need for full recertification.

Curious about how artificial intelligence is transforming psychiatry?

🎙️Tune in to the latest episode of the InnoStars Talks podcast, where Dr Marlena Sokoł-Szawlowska from the Institute of Psychiatry and Neurology in Warsaw, the innovator behind MoodMon, discusses this AI-powered tool for detecting and managing affective disorders such as depression and bipolar disorder.